The aim of this retrospective study was to evaluate in a historical series of patients whether morphological changes of the urinary tract imaged on intravenous urography (IVU) are associated with clinical or urodynamic data.
Methods
During a 1-year period, every man 45 years or older with lower urinary tract symptoms suggestive of benign prostatic hyperplasia was systematically evaluated with multi-channel computer-urodynamic investigation and IVU. Men with urinary retention, known bladder stones or diverticula, severely impaired renal function, or allergy to iodine contrast media were excluded. Structural alterations of the urinary tract were correlated with clinical and urodynamic data using logistic regression analysis.
Results
Data on 203 consecutive patients were available for analysis. Multivariate analysis demonstrated that the “fish-hook” configuration of the distal ureter (also known as “hockey-stick”, or “J-shaped” ureter) was the only sign significantly associated with benign prostatic obstruction (BPO) (odds-ratio 3.64; 95% confidence interval 1.69–7.83; P < 0.001). The sensitivity, specificity, positive and negative predictive values of the “fish-hook” ureter configuration sign to detect BPO was 53, 76, 61 and 70%, respectively. Bladder trabeculation, upper urinary tract dilatation, or bladder base elevation were not associated with BPO, detrusor overactivity, detrusor underactivity, bladder low-compliance or any clinical data.
Conclusions
The “fish-hook” shape of the distal ureter(s) indicates BPO and may be a result of prostate median lobe enlargement.
Abkürzungen
BPH
Benign prostatic hyperplasia
BPO
Benign prostatic obstruction
BPE
Benign prostatic enlargement
CI
Confidence interval
IPP
Intravesical prostatic protrusion
IPSS
International prostate symptom score
IVU
Intravenous urography
LUTS
Lower urinary tract symptoms
OR
Odds ratio
PVR
Post-void residual urine
TRUS
Transrectal ultrasound
UDI
Urodynamic investigation
Introduction
Benign prostatic hyperplasia (BPH) is the term used to describe the growth of epithelial, muscular and/or fibrotic cells in the prostate [1]. BPH may be associated with benign prostatic enlargement (BPE), lower urinary tract symptoms (LUTS) and benign prostatic obstruction (BPO), although no clear correlations among the components have been found so far [2‐5]. BPH starts affecting men by their fourth decade and occurs in up to 90% in the ninth decade [6]. It is ranked fifth among the ten most frequently treated diseases in Western countries [7] and responsible for a high socio-economic burden in ageing societies.
Intravenous urography (IVU) is a radiological tool for the assessment of BPH-related changes of the upper/lower urinary tract (e.g. hydronephrosis, trabeculation, diverticula and bladder stones) and other urological diseases (e.g. nephro-/ureterolithiasis and upper urinary tract tumours). Despite its excellent diagnostic value, IVU was abandoned for routine work-up of patients with BPH in most Western countries in 1990s due to increased radiation risks, costs, and low additional diagnostic benefit compared to ultrasonography [8‐11]. Nevertheless, IVU remains a valid tool to evaluate upper urinary tract pathology (stones, tumours) and haematuria until today. Therefore, physicians must still be familiar with IVU to properly judge the urinary tract.
Anzeige
This study aims to retrospectively investigate clinical and urodynamic data in a cohort of BPH–LUTS patients and correlate them with IVU signs to evaluate a potential association with morphological changes of the urinary tract in an attempt to contribute to the pathophysiology of the disease.
Materials and methods
Inclusion and exclusion criteria
During 1st January and 31st December 1994, all men aged ≥45 years with BPH–LUTS referred to the Department of Urology, Hannover Medical School were systematically investigated according to the department policy with (a) medical history focusing on LUTS, (b) physical (digito-rectal) examination, (c) International Prostate Symptom Score (IPSS), (d) urinalysis, (e) laboratory tests including prostate specific antigen and creatinine levels, (f) transrectal prostate ultrasound (TRUS), (g) free uroflowmetry and measurement of postvoid residual (PVR) urine, (h) multi-channel computer-urodynamic investigation (UDI), and (i) intravenous urography (IVU).
Men with an indwelling bladder catheter, impaired renal function (serum-creatinine >180 μmol/l), known bladder stones/diverticula, or allergy to iodine contrast media received a reduced work-up (a–f). Men with a neurological deficit, previous lower urinary tract or pelvis operations, known prostate or transitional cell cancer, or 5α-reductase inhibitors were excluded. Only men with a complete work-up (a–i) were included in the study.
Assessment protocol
All investigations were performed as outpatient procedures during two visits. Medical history, physical examination, urine as well as blood samples were taken. TRUS was performed with a 7.5 MHz array and prostate volume was determined by measuring the greatest transverse and longitudinal dimensions. Free uroflowmetry was done when the patient reported a full bladder; a minimal voided urine volume of 150 ml was considered acceptable to judge maximum urinary flow rate (Qmax). PVR was measured immediately after voiding using a 3.5 MHz ultrasound array measuring the greatest bladder transverse and longitudinal distances. Free uroflowmetry and PVR measurements were repeated at least once and the highest Qmax/lowest PVR were used for analysis. Patients were asked to complete the IPSS questionnaire and deliver their answers at the second visit.
Anzeige
IVU and UDI were performed one to 3 weeks after initial presentation if renal function and urinalysis were appropriate. Three IVU images were taken in the lying position; the first before and the second and third five and 15 min after contrast media infusion (100 ml Solutrast™ 300), respectively. UDI was performed using a 7F transurethral microtip and a 12F rectal catheter. The bladder was filled with physiological saline solution of 37°C at a rate of 25–50 ml/min. Methods, definitions and units were in line with the International Continence Society recommendations [1]. UDI were conducted at least twice and the lowest degree of BPO, based on the Schäfer classification [12], was used for analysis.
Evaluation of morphological and functional signs
Structural alterations of the urinary tract on IVU were correlated with clinical and urodynamic data using logistic regression analysis. We focused on the following binary dependent variables based on IVU findings (Fig. 1): (a) urinary tract calcifications, (b) delayed excretion of contrast media, (c) upper urinary tract dilatation of any degree, (d) peristalsis of the ureter(s), (e) uni- or bilateral “fish-hook” configuration of the distal ureter (“hockey-stick” or “J-shaped” ureter), (f) delayed emptying of the ureter(s), (g) bladder base elevation of any degree, (h) bladder diverticula unknown prior to investigation and/or trabeculation.
Fig. 1
Intravenous urography imaging the urinary tract 15 min after contrast media infusion showing bilateral “fish-hook” ureters (→) and hydronephrosis in an 64-year old men with BPH–LUTS (a) as well as a unilateral “fish-hook” ureter (→) and elevated bladder base (*) in an 70-year old man with BPH–LUTS (b)
×
The following urodynamic variables were tested as potential predictors of the dependent variables (univariable analysis): (a) normal/low bladder compliance, (b) presence/absence of detrusor overactivity, (c) amplitude of uninhibited detrusor contractions in patients with detrusor overactivity, (d) presence/absence of detrusor overactivity incontinence, (e) normal/week detrusor work during voiding (DAMPF [12]), (f) presence/absence of BPO (Schäfer nomogram). Significant predictors detected were further evaluated after adjusting for possible confounding patient characteristics, namely age, prostate volume, PVR and bladder capacity at UDI.
Results
Data on 203 men were available for analysis. General patient characteristics and the number of patients with the specific IVU or urodynamic findings are summarized in Table 1. Univariable binary logistic regression analysis revealed
Table 1
General patient characteristics (A) and findings on intravenous urography (B) or computer-urodynamic investigation (C)
A. General patient characteristics
Median (interquartile range)
Age (years)
63 (13)
Body mass index (kg/m2)
25.4 (3.8)
International prostate symptom score, IPSS
15 (11)
Quality of life score on IPSS
3 (2)
Serum creatinine level (μmol/l)
87 (22)
Serum prostate specific antigen concentration (μg/l)
2.1 (3.7)
Prostate volume on transrectal ultrasound (ml)
40 (29)
Maximum flow rate (ml/sec)a
12.6 (8.2)
Post-void residual urine (ml)a
50 (122)
Bladder capacity on urodynamic investigation (ml)
345 (279)
B. Specific signs on intravenous urography
Number of affected mend (%)
Urinary tract calcifications (stones)
17 (8.5)
Urinary tract dilatation (hydronephrosis)
16 (5.5)
Complete filling of the ureter with contrast media
64 (31.7)
Fish-hook configuration of distal ureter(s), total
72 (36.0)
Unilateral
43 (21.5)
Bilateral
29 (14.5)
Delayed unilateral renal excretion of contrast media
11 (5.4)
Delayed emptying of ureter(s)
6 (3.0)
Bladder base elevation
112 (55.7)
Bladder diverticula and/or trabeculation
49 (24.5)
C. Specific signs at computer-urodynamic investigation
Number of affected mend (%)
Low bladder compliance (≤25 ml/cm H2O)
28 (14.2)
Detrusor overactivityb
118 (59.3)
Detrusor overactivity incontinence
21 (10.7)
Weak/very weak detrusor work (DAMPF)
11 (5.4)
Benign prostatic obstruction (Schäfer nomogram)c
83 (40.9)
aBased on a free uroflow with voided volume of at least 150 ml
bDefined as involuntary detrusor contraction(s) with amplitude ≥10 cm H2O
cPatients classified as Schäfer 0, I or II were considered not obstructed
dMore than one sign possible in a single patient
presence of stones was significantly associated with low bladder compliance (OR 3.84, 95% CI: 1.29–11.43; P = 0.016),
elevation of the bladder base was significantly associated with BPO (OR 2.01, 95% CI: 1.14–3.54; P = 0.016),
“fish-hooked” configuration of the distal ureter(s) was significantly associated with BPO (OR 3.59, 95% CI: 1.96–6.57; P < 0.001).
When potential confounding variables (age, prostate volume, PVR, and bladder capacity) were taken into account in the respective multivariate regression models to test the aforementioned significant associations, only the association between the “fish-hook” ureter(s) and BPO remained significant (Table 2; models for stones and bladder base elevation with insignificant findings not shown). Based on the multivariate regression model, BPO was the only independent predictor of “fish-hook” ureters.
Table 2
Logistic regression model for the prediction of the “fish-hook” configuration of the distal ureter (uni- or bilateral)
Variables
Regression coefficient
Standard error
Odds ratio
95% Confidence intervals
P value
Age (years)
−0.014
0.024
0.986
0.941–1.034
0.565
Prostate volume (ml)
−0.003
0.006
0.997
0.985–1.009
0.616
Post-void residual urine(ml)
0.000
0.001
1.000
0.998–1.003
0.835
Bladder capacity (ml)
0.001
0.001
1.001
0.999–1.003
0.221
Benign prostatic obstruction (Schäfer nomogram)a
1.291
0.391
3.638
1.691–7.827
0.001
Constant (b0)
−0.070
1.660
0.933
0.966
Hosmer and lemeshow test: P = 0.329
Two hundred patients were available, whereas three patients without BPO did not show contrast media filling of the distal ureters and, hence, were excluded from analysis
Significant value is indicated in bold
aReference category: non obstruction (Schäfer 0, I, II)
The sensitivity, specificity, positive and negative predictive values of “fish-hook” ureter(s) to diagnose BPO was 53, 76, 61 and 70%, respectively, resulting in an overall test accuracy of 67%. The likelihood ratio of a positive test result was 2.22 (95% CI 1.51–3.24; Table 3).
Table 3
Distribution of patients with or without “fish-hook” ureter(s) in the absence or presence of BPO
Fish-hook ureter(s)
Benign prostatic obstruction
Presentb
Absentc
Presenta
44
28
Absent
39
89
Two hundred patients were available for evaluation of the test accuracy of this particular radiological sign; 3 patients without BPO did not show contrast media filling of the distal ureters and were excluded from calculation
aUni- or bilateral
bSchäfer classes III-VI
cSchäfer classes 0-II
Table 4 demonstrates the general characteristics of patients with or without the “fish-hook” sign of the distal ureter(s) indicating a significantly greater prostate volume and higher serum PSA level in the former subgroup.
Table 4
Comparison of clinical data in patients with or without the “fish-hook” sign of the distal ureter
Parameter
Patients with “fish-hook” ureter(s)
Patients without “fish-hook” ureter(s)
P value
Age (years)
63.5 (12.0)
62.0 (13.0)
0.410
Body mass index(kg/m2)
25.2 (3.3)
25.5 (4.3)
0.952
Serum creatinine level (μmol/l)
84 (21)
88 (21)
0.234
International Prostate Symptom Score, IPSS 1–7
15 (11)
14 (10)
0.828
Quality of life score, IPSS 8
3 (3)
4 (2)
0.305
Serum prostate specific antigen (PSA) level (ng/ml)
2.8 (5.9)
1.8 (2.8)
0.028
Prostate volume on transrectal ultrasound (ml)
44 (37)
36 (22)
0.035
Post-void residual urine (ml)
49 (100)
48 (116)
0.997
Maximum urinary flow rate (ml/sec)
12.0 (4.7)
13.0 (9.4)
0.086
Bladder capacity on urodynamic investigation (ml)
349 (302)
343 (223)
0.538
Results are presented as median (interquartile range)
Significant values are indicated in bold
Discussion
We investigated in a historical group of unselected patients with BPH–LUTS the relationship between morphological and functional signs of the urinary tract, determined by IVU and UDI, respectively. The “fish-hook” shape of the distal ureter(s) was found to be significantly associated with BPO. To the best of our knowledge, we present for the first time urodynamic evidence for this association. The “fish-hook” ureter has been described in many urological textbooks [13‐15] and was regarded as a sign of BPE [16, 17].
Anzeige
According to the department policy, every man with BPH–LUTS was investigated with the identical assessment protocol in 1994. Only patients with other possible causes of LUTS and those unsuitable for IVU or UDI were excluded. Men with known bladder stones, diverticula, or urinary retention were deprived of UDI because they were considered obstructed [18] and were submitted directly to prostate surgery. Consequently, our study group consisted of 203 consecutive patients who were able to void and considered to have uncomplicated BPH–LUTS. Inclusion of more patients might have resulted in selection bias, because UDI was incomplete during 1991–1993 and IVU for the routine assessment of patients with BPH–LUTS was rarely performed in 1995 and finally abandoned in our department in 1996. A similar study today using IVU or CT imaging does not seem to be ethically justified due to the risks of radiation but might be conducted using MRI urography instead. However, ethical approval was not necessary at that time and therefore not obtained since all tests were considered necessary for the routine assessment of patients with BPH–LUTS in 1994.
Our aim was to evaluate the relationships between morphological and functional changes of the urinary tract and, therefore, shed light on the pathophysiology of BPH–LUTS rather than to advertise IVU as a routine test for this patient group. Although the “fish-hook” configuration of the distal ureter(s) is significantly associated with BPO, this radiological sign appears unsuitable for routine evaluation of BPO because its diagnostic value is clearly lower than that of other non-invasive tests, such as ultrasonic measurements of IPP [19, 20] or detrusor wall thickness [21, 22]. Nevertheless, the knowledge that the “fish-hook” sign appears in the presence of BPO might motivate physicians to evaluate for BPO whenever it is visible.
The “fish-hook” shape of the distal ureter seems to be an indirect sign of BPO and might be caused by a prostate median lobe elevating the trigone, displacing the ureteral orifice, and deforming the distal ureter. Prostate median lobe enlargement with intravesical prostatic protrusion (IPP) >10 mm has been described as a significant predictor of BPO [19, 20]. The association between IPP and BPO was first described in 2003 and, therefore, unknown and not evaluated in 1994. In contrast to IPP, bladder base elevation is not only caused by prostate median lobe but also prostate lateral lobe enlargement; this might explain why the radiological sign of the elevated bladder base (seen in 55.7% of our patients) was not an independent predictor of BPO (seen in 40.9% of our patients).
Interestingly, we failed to show significant associations between BPO and other structural alterations of the urinary tract. Bladder trabeculation showed no association with BPO or detrusor overactivity; these findings are in accordance with previous studies [23]. We also could not demonstrate any association between BPO and hydronephrosis; this stands in contrast to others who demonstrated a decreasing bladder compliance with increasing BPO grade [24] and an increasing tendency of upper urinary tract dilation with decreasing compliance [25]. Since IVU was not conducted in patients with creatinine levels >180 μmol/l, the number of patients with bilateral upper urinary tract dilation (n = 16) without impaired renal function might have been insufficient to show this relationship. Bladder stones or diverticula were considered per se as signs of BPO; these patients were treated by prostate surgery without UDI. Although bladder stones or diverticula are generally believed to be the result of BPO, only the association between bladder stones and BPO is evidence based [18].
Anzeige
Conclusions
The “fish-hook” configuration of the distal ureter(s) is associated with BPO. Whenever this radiological sign is detected in older men, for example during routine assessment of urolithiasis or haematuria, the patient should be evaluated for BPO and counselled accordingly.
Acknowledgments
The authors gratefully acknowledge the skilful and enthusiastic collection of the patients’ data by Dr. Wibke Knöner.
Conflict of interest
The authors declare no conflict of interest.
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Anzeige
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Mit e.Med Gynäkologie erhalten Sie Zugang zu CME-Fortbildungen der beiden Fachgebiete, den Premium-Inhalten der Fachzeitschriften, inklusive einer gedruckten gynäkologischen oder urologischen Zeitschrift Ihrer Wahl.
Die akute Zystitis von Männern und ihre Therapie sind wenig erforscht. Norwegische Forscher haben das nachgeholt. Ihr Rat: Erst einmal keine Breitbandantibiotika verordnen.
Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.
D-Mannose, eine Hoffnungsträgerin in der Rezidivprophylaxe von Harnwegsinfektionen, hat in einer Studie nicht mehr bewirken können als ein Placebo. Die Empfehlung zur Einnahme entfalle damit, so die Autoren.
Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.
Update Urologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
